{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:54:52Z","timestamp":1793123692613,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jaad.2009.05.030","type":"journal-article","created":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T05:35:20Z","timestamp":1268631320000},"page":"646-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"title":["Pyoderma gangrenosum: A review and update on new therapies"],"prefix":"10.1016","volume":"62","author":[{"given":"Jeremiah","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad A.","family":"Yentzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Jorizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.05.030_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","article-title":"Pyoderma gangrenosum: classification and management","volume":"34","author":"Powell","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200001000-00004","article-title":"Pyoderma gangrenosum: a comparison of typical and atypical forms with an emphasis on time to remission; case review of 86 patients from 2 institutions","volume":"79","author":"Bennett","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2009.05.030_bib3","series-title":"Andrews' diseases of the skin: clinical dermatology","author":"Odom","year":"2000"},{"key":"10.1016\/j.jaad.2009.05.030_bib4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-2133.2007.08217.x","article-title":"Treatment of pyoderma gangrenosum with intravenous immunoglobulin","volume":"157","author":"Cummins","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jamcollsurg.2007.07.023","article-title":"Management of peristomal pyoderma gangrenosum","volume":"206","author":"Poritz","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jaad.2009.05.030_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jaad.2007.08.048","article-title":"Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings","volume":"58","author":"Fonder","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-2-19","article-title":"Pyoderma gangrenosum\u2013a review","volume":"2","author":"Wollina","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaad.2009.05.030_bib8","first-page":"313","article-title":"Pyoderma gangrenosum: a case study for pain management in dermatology nursing","volume":"12","author":"Dunwoody","year":"2000","journal-title":"Dermatol Nurs"},{"key":"10.1016\/j.jaad.2009.05.030_bib9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1365-2133.1997.20022083.x","article-title":"Pyoderma gangrenosum: a report of 44 cases with follow-up","volume":"137","author":"von den","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1346-8138.2006.00055.x","article-title":"Topical tacrolimus for pyoderma gangrenosum: another report","volume":"33","author":"Piccirillo","year":"2006","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1468-3083.2007.02280.x","article-title":"Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%","volume":"22","author":"Bellini","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.05.030_bib12","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1365-2133.2004.05914.x","article-title":"Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum","volume":"150","author":"Ghislain","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/00015550510040923","article-title":"Systemic absorption of topical tacrolimus in pyoderma gangrenosum","volume":"86","author":"Pitarch","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2009.05.030_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000065843","article-title":"Topical treatment of pyoderma gangrenosum","volume":"205","author":"Wenzel","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.05.030_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000246377","article-title":"Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum","volume":"192","author":"Tamir","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.05.030_bib16","first-page":"459","article-title":"Topical disodium cromoglycate in the management of pyoderma gangrenosum","volume":"42","author":"Massone","year":"1988","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2009.05.030_bib17","first-page":"262","article-title":"Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid","volume":"51","author":"Sanders","year":"1993","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2009.05.030_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2230.1992.tb00254.x","article-title":"Pyoderma gangrenosum\u2013response to topical nitrogen mustard","volume":"17","author":"Tsele","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2008.01.009","article-title":"Non-melanoma skin cancer: importance of gender, immunosuppressive status and vitamin D","volume":"261","author":"Oberyszyn","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jaad.2009.05.030_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomized, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jaad.2009.05.030_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.sder.2006.08.006","article-title":"Off-label uses of biologic agents in dermatology: a 2006 update","volume":"25","author":"Kerns","year":"2006","journal-title":"Semin Cutan Med Surg"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.030_bib22","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.jaad.2005.10.058","article-title":"The treatment of pyoderma gangrenosum using etanercept","volume":"54","author":"Roy","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2230.2005.01972.x","article-title":"Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept)","volume":"31","author":"Pastor","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib24","first-page":"441","article-title":"Treatment of pyoderma gangrenosum with etanercept","volume":"3","author":"McGowan","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09546630500424722","article-title":"Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis","volume":"16","author":"Goldenberg","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2009.05.030_bib26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-4632.2007.03286.x","article-title":"Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series","volume":"46","author":"Charles","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-4632.2008.03412.x","article-title":"Pyoderma gangrenosum\u2013rebel without a cure?","volume":"47","author":"Jacob","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib28","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1365-2133.2007.08212.x","article-title":"Adalimumab for treatment of pyoderma gangrenosum","volume":"157","author":"Pomerantz","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib29","first-page":"e8","article-title":"Adalimumab therapy for recalcitrant pyoderma gangrenosum","volume":"5","author":"Fonder","year":"2006","journal-title":"J Burns Wounds"},{"key":"10.1016\/j.jaad.2009.05.030_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MPG.0b013e318124504b","article-title":"Adalimumab induces and maintains remission in severe, resistant pediatric Crohn disease","volume":"46","author":"Hadziselimovic","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaad.2009.05.030_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archderm.143.3.306","article-title":"Adalimumab treatment for pyoderma gangrenosum","volume":"143","author":"Heffernan","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib32","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2133.2005.06467.x","article-title":"Systemic pyoderma gangrenosum responding to infliximab and adalimumab","volume":"152","author":"Hubbard","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib33","unstructured":"Woodson J. Use of efalizumab for the successful treatment of chronic recalcitrant pyoderma gangrenosum. Poster presented at: 64th Annual Meeting of the American Academy of Dermatology; March 3-7, 2006; San Francisco, CA."},{"key":"10.1016\/j.jaad.2009.05.030_bib34","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1468-3083.2008.02680.x","article-title":"An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum","volume":"22","author":"Foss","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.05.030_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1744-9987.2007.00424.x","article-title":"Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum","volume":"11","author":"Seishima","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaad.2009.05.030_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000080079","article-title":"Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis","volume":"70","author":"Hanai","year":"2004","journal-title":"Digestion"},{"key":"10.1016\/j.jaad.2009.05.030_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1381612033391928","article-title":"Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column","volume":"9","author":"Sawada","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaad.2009.05.030_bib38","series-title":"Dermatology","author":"Bolognia","year":"2008"},{"key":"10.1016\/j.jaad.2009.05.030_bib39","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s10350-004-0944-x","article-title":"Management of peristomal pyoderma gangrenosum","volume":"48","author":"Kiran","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jaad.2009.05.030_bib40","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1080\/003655202320378338","article-title":"Pyoderma gangrenosum associated with Crohn disease: effect of TNF-alpha blockade with infliximab","volume":"37","author":"Ljung","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.05.030_bib41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2230.2004.01681.x","article-title":"Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab","volume":"30","author":"Swale","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib42","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2133.2003.05760.x","article-title":"Successful treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumor necrosis factor antibody)","volume":"150","author":"Jenne","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2230.2004.01470.x","article-title":"Infliximab as a treatment for recalcitrant pyoderma gangrenosum","volume":"29","author":"Singh","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00296-004-0467-8","article-title":"The effect of infliximab on extraintestinal manifestations of Crohn's disease","volume":"25","author":"Kaufman","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaad.2009.05.030_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/03009740510026698","article-title":"Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease","volume":"34","author":"Rispo","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1525-1470.2005.22320.x","article-title":"Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome","volume":"22","author":"Stichweh","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000111515","article-title":"Treatment of idiopathic pyoderma gangrenosum with infliximab: induction dosing regimen or on-demand therapy?","volume":"216","author":"Adisen","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.05.030_bib48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000106584","article-title":"Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis: case report and literature review","volume":"215","author":"Juillerat","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.05.030_bib49","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1023\/B:DDAS.0000042245.20042.4f","article-title":"Treatment of pyoderma gangrenosum with infliximab in Crohn's disease","volume":"49","author":"Sapienza","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaad.2009.05.030_bib50","first-page":"173","article-title":"Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease","volume":"15","author":"Ferkolj","year":"2006","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1016\/j.jaad.2009.05.030_bib51","first-page":"401","article-title":"Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease: a case report","volume":"14","author":"Kouklakis","year":"2005","journal-title":"Rom J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.05.030_bib52","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/ibd.20181","article-title":"Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases","volume":"13","author":"Cocco","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2009.05.030_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1440-0960.2007.00344.x","article-title":"Use of infliximab in pyoderma gangrenosum","volume":"48","author":"Hewitt","year":"2007","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib54","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","article-title":"Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"98","author":"Regueiro","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.05.030_bib55","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2230.2004.01716.x","article-title":"Successful treatment of recalcitrant pyoderma gangrenosum with infliximab complicated by tuberculosis despite negative screening tests","volume":"30","author":"Uthman","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib56","first-page":"420","article-title":"Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab","volume":"96","author":"Lopez San","year":"2004","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jaad.2009.05.030_bib57","first-page":"150","article-title":"Dermatologic manifestations of Crohn disease in children: response to infliximab","volume":"37","author":"Kugathasan","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaad.2009.05.030_bib58","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2133.2003.05294.x","article-title":"Infliximab for peristomal pyoderma gangrenosum","volume":"148","author":"Mimouni","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib59","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000065860","article-title":"Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab","volume":"205","author":"Grange","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.05.030_bib60","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/gas.37.7.863.865","article-title":"Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum","volume":"37","author":"Triantafillidis","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.05.030_bib61","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/00042737-200208000-00021","article-title":"Infliximab induces remission of pyoderma gangrenosum","volume":"14","author":"Romero-Gomez","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2009.05.030_bib62","first-page":"558","article-title":"Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease","volume":"34","author":"Batres","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaad.2009.05.030_bib63","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0190-9622(96)90285-6","article-title":"Treatment of pyoderma gangrenosum","volume":"34","author":"Chow","year":"1996","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209006707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209006707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:15:35Z","timestamp":1759270535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209006707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0190962209006707"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.05.030","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyoderma gangrenosum: A review and update on new therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}